Institute of Medical Sciences and Sum Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2021

  1. Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study

    Journal of Hematology and Oncology